Published in World J Surg on March 01, 2011
Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis (2014) 1.31
Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg (2013) 0.85
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma. Radiat Oncol (2013) 0.84
Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med (2014) 0.84
Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma. J Gastrointest Oncol (2014) 0.77
Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure. Eur Arch Otorhinolaryngol (2015) 0.77
Management algorithm for failed gastric pull up reconstruction of laryngopharyngectomy defects: case report and review of the literature. J Otolaryngol Head Neck Surg (2016) 0.75
Pros and cons of the gasless laparoscopic transhiatal esophagectomy for upper esophageal carcinoma. Surg Endosc (2015) 0.75
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med (1992) 7.40
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol (1997) 2.73
TNM residual tumor classification revisited. Cancer (2002) 2.50
Pharyngolaryngectomy, with immediate pharyngogastric anastomosis. Br J Surg (1966) 2.36
Thoracoscopic esophagectomy for esophageal cancer. Surgery (1997) 1.60
Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus. Br J Surg (1960) 1.52
Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg (2001) 1.35
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1998) 1.29
Surgical treatment and clinical course of patients with hypopharyngeal carcinoma. Dis Esophagus (2006) 0.97
Gastric transposition in head and neck surgery. Indications, complications, and expectations. Am J Surg (1983) 0.96
Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg (2000) 0.95
Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol (2006) 0.92
Pharyngolaryngoesophagectomy with pharyngogastric anastomosis for cancer of the hypopharynx: review of 101 operations. Head Neck Surg (1986) 0.92
Pharyngogastric anastomosis following pharyngolaryngoesophagectomy. Analysis of 157 cases. World J Surg (1981) 0.87
Gastric transposition for head and neck cancer: a critical update. Am J Surg (1991) 0.87
Current status of pharyngolaryngo-esophagectomy and pharyngogastric anastomosis. Head Neck (1998) 0.87
Carcinoma of the cervical esophagus: diagnosis, management, and results. South Med J (1984) 0.87
A third decade's experience with the gastric pull-up operation for hypopharyngeal carcinoma: changing patterns of use. J Laryngol Otol (1999) 0.83
Minimal invasive approach of gastric and esophageal mobilization in total pharyngolaryngoesophagectomy: total laparoscopic and hand-assisted laparoscopic technique. Surg Endosc (2003) 0.82
The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer (1983) 0.82
Anterior mediastinal tracheostomy with and without cervical exenteration. Ann Thorac Surg (1992) 0.81
Pharyngolaryngoesophagectomy using the thoracoscopic approach. Surg Endosc (2006) 0.80
Present status of pharyngogastric anastomosis following pharyngolaryngo-oesophagectomy. Br J Surg (1987) 0.80
Therapeutic options for cancer of the hypopharynx and cervical oesophagus. Ann Chir Gynaecol (1995) 0.80
Gastric pull-up reconstruction for pharyngo-laryngo-esophagectomy. Arch Surg (1994) 0.76
Mortality and morbidity of primary pharyngogastric anastomosis following circumferential excision for hypopharyngeal malignancies. J Surg Oncol (1990) 0.76
Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus (2007) 0.76
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet (2011) 5.68
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
Variation in gene expression patterns in human gastric cancers. Mol Biol Cell (2003) 2.39
Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer (2011) 2.09
Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01
Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer (2003) 1.94
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol (2010) 1.71
Reconstruction of circumferential pharyngeal defects after tumour resection: reference or preference. J Plast Reconstr Aesthet Surg (2011) 1.61
Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg (2008) 1.46
Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck (2005) 1.39
Colonic interposition after esophagectomy for cancer. Arch Surg (2003) 1.38
Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study. Head Neck (2005) 1.31
Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res (2005) 1.29
A prospective evaluation of catheter probe EUS for the detection of ascites in patients with gastric carcinoma. Gastrointest Endosc (2004) 1.24
Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology (2004) 1.23
Iatrogenic Chilaiditi's syndrome. Gastrointest Endosc (2002) 1.16
Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol (2002) 1.16
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.13
A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res (2013) 1.12
Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 25-year experience. Head Neck (2006) 1.10
Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg (2003) 1.10
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg (2005) 1.09
Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene (2005) 1.08
Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer. PLoS One (2012) 1.08
Outcome of craniofacial surgery in children and adolescents with malignant tumors involving the skull base: an international collaborative study. Head Neck (2009) 1.08
Microvascular free flaps: a major advance in head and neck reconstruction. Acta Otolaryngol (2002) 1.07
Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma. Head Neck (2008) 1.06
Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol (2004) 1.06
Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet (2006) 1.06
Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Int J Cancer (2003) 1.06
Cervical spine complications after treatment of nasopharyngeal carcinoma. Eur Spine J (2012) 1.05
Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. J Clin Microbiol (2004) 1.04
Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol (2010) 1.03
Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol (2004) 1.02
Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base (2012) 1.02
Nasal Retinoschisis Associated with Glaucoma. Ophthalmic Surg Lasers Imaging (2010) 1.02
A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg (2008) 1.02
Endoscopic resection of malignant tumors of the nose and sinuses. Am J Rhinol (2007) 0.99
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer. Jpn J Clin Oncol (2008) 0.99
The influence of technical complications on postoperative outcome and survival after esophagectomy. Ann Surg Oncol (2006) 0.99
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer (2011) 0.97
Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. Ann Surg Oncol (2007) 0.97
Surgical salvage of persistent or recurrent nasopharyngeal carcinoma with maxillary swing approach - Critical appraisal after 2 decades. Head Neck (2010) 0.97
Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol (2003) 0.96
AtWRKY40 and AtWRKY63 modulate the expression of stress-responsive nuclear genes encoding mitochondrial and chloroplast proteins. Plant Physiol (2013) 0.96
Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: implications for carcinogenesis. Cancer Lett (2010) 0.95
Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res (2010) 0.95
Combined transnasal endoscopic and transoral robotic resection of recurrent nasopharyngeal carcinoma. Head Neck (2011) 0.94
Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma. Int J Mol Med (2007) 0.94
Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg (2012) 0.94
Medialisation thyroplasty for unilateral vocal fold paralysis associated with chronic pulmonary tuberculosis. Hong Kong Med J (2007) 0.94
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome. Int J Cancer (2010) 0.92
Esophageal cancer in patients with a history of distal gastrectomy. Arch Surg (2002) 0.92
Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2007) 0.91
Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol (2006) 0.91
Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior. Endocr Pathol (2005) 0.91
Management of the orbit in malignant sinonasal tumors. Head Neck (2008) 0.90
AtPAP2 is a tail-anchored protein in the outer membrane of chloroplasts and mitochondria. Plant Signal Behav (2012) 0.90
Cross-cultural adaptation and validation of the Chinese Voice Handicap Index-10. Laryngoscope (2006) 0.90
Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma. Int J Cancer (2008) 0.89
The Kirschner operation in unresectable esophageal cancer: current application. Arch Surg (2002) 0.89
Time course in the relief of nasal blockage after septal and turbinate surgery: a prospective study. Arch Otolaryngol Head Neck Surg (2004) 0.88
Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Cancer Epidemiol (2013) 0.88
Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer (2005) 0.88
Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. Cancer Lett (2007) 0.88
Randomized evaluation of the audiologic outcome of ventilation tube insertion for middle ear effusion in patients with nasopharyngeal carcinoma. J Otolaryngol (2002) 0.87
A prospective controlled double-blind trial of great auricular nerve preservation at parotidectomy. Am J Surg (2003) 0.87
Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope (2014) 0.87
Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int J Cancer (2008) 0.87
Elimination of palatal fistula after the maxillary swing procedure. Head Neck (2005) 0.86
Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett (2006) 0.86
Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study. Arch Otolaryngol Head Neck Surg (2006) 0.86
Laparoscopic surgery induced interleukin-6 levels in serum and gut mucosa: implications of peritoneum integrity and gas factors. Surg Endosc (2008) 0.85
Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient. Clin Cancer Res (2003) 0.85
Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge? Ann Surg Oncol (2008) 0.85
Nasopharyngectomy for locally advanced recurrent nasopharyngeal carcinoma: exploring the limits. Head Neck (2011) 0.85
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck (2006) 0.85
Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma. Head Neck (2003) 0.84
Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics. World J Gastroenterol (2005) 0.84
Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res (2008) 0.84
Change in olfaction after radiotherapy for nasopharyngeal cancer--a prospective study. Am J Otolaryngol (2002) 0.84
The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma. Cancer Lett (2011) 0.84
Classification of in vivo autofluorescence spectra using support vector machines. J Biomed Opt (2004) 0.84
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression. Cancer Sci (2012) 0.84
Cytogenetic and fluorescence in situ hybridization characterization of clonal chromosomal aberrations and CCND1 amplification in esophageal carcinomas. Cancer Genet Cytogenet (2004) 0.83
Triptans for acute cluster headache. Cochrane Database Syst Rev (2013) 0.83
Combined endovascular stent grafting and endoscopic injection of fibrin sealant for aortoenteric fistula complicating esophagectomy. J Vasc Surg (2004) 0.82
Comparisons of sixth and seventh edition of the American Joint Cancer Committee staging systems for esophageal cancer. Ann Surg Oncol (2013) 0.82
Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma. Int J Mol Med (2006) 0.82
Lipopolysaccharide-induced toll-like receptor 4 signaling enhances the migratory ability of human esophageal cancer cells in a selectin-dependent manner. Surgery (2013) 0.82
Managing disturbing snoring with palatal implants: a pilot study. Arch Otolaryngol Head Neck Surg (2004) 0.81
Systemic inflammatory response after natural orifice translumenal surgery: transvaginal cholecystectomy in a porcine model. JSLS (2009) 0.81